IGSF2
From Wikipedia, the free encyclopedia
|
Immunoglobulin superfamily, member 2
|
|||||||||||
| Identifiers | |||||||||||
| Symbol(s) | IGSF2; CD101; V7 | ||||||||||
| External IDs | OMIM: 604516 HomoloGene: 3142 | ||||||||||
|
|||||||||||
| RNA expression pattern | |||||||||||
|
|
|||||||||||
| Orthologs | |||||||||||
| Human | Mouse | ||||||||||
| Entrez | 9398 | n/a | |||||||||
| Ensembl | ENSG00000134256 | n/a | |||||||||
| Uniprot | Q93033 | n/a | |||||||||
| Refseq | NM_004258 (mRNA) NP_004249 (protein) |
n/a (mRNA) n/a (protein) |
|||||||||
| Location | Chr 1: 117.35 - 117.38 Mb | n/a | |||||||||
| Pubmed search | [1] | n/a | |||||||||
Immunoglobulin superfamily, member 2 (IGSF2) also known as CD101 (Cluster of Differentiation 101), is a human gene.[1]
Contents |
[edit] See also
[edit] References
[edit] Further reading
- Rivas A, Ruegg CL, Zeitung J, et al. (1995). "V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies.". J. Immunol. 154 (9): 4423-33. PMID 7722299.
- Ruegg CL, Rivas A, Madani ND, et al. (1995). "V7, a novel leukocyte surface protein that participates in T cell activation. II. Molecular cloning and characterization of the V7 gene.". J. Immunol. 154 (9): 4434-43. PMID 7722300.
- Soares LR, Rivas A, Tsavaler L, Engleman EG (1997). "Ligation of the V7 molecule on T cells blocks anergy induction through a CD28-independent mechanism.". J. Immunol. 159 (3): 1115-24. PMID 9233604.
- Bagot M, Martinel I, Charue D, et al. (1998). "CD101 is expressed by skin dendritic cells. Role in T-lymphocyte activation.". Tissue Antigens 50 (5): 439-48. PMID 9389317.
- Soares LR, Tsavaler L, Rivas A, Engleman EG (1998). "V7 (CD101) ligation inhibits TCR/CD3-induced IL-2 production by blocking Ca2+ flux and nuclear factor of activated T cell nuclear translocation.". J. Immunol. 161 (1): 209-17. PMID 9647226.
- Bouloc A, Boulland ML, Geissmann F, et al. (2000). "CD101 expression by Langerhans cell histiocytosis cells.". Histopathology 36 (3): 229-32. PMID 10692025.
- Bouloc A, Bagot M, Delaire S, et al. (2001). "Triggering CD101 molecule on human cutaneous dendritic cells inhibits T cell proliferation via IL-10 production.". Eur. J. Immunol. 30 (11): 3132-9. PMID 11093127.
- Stipp CS, Kolesnikova TV, Hemler ME (2001). "EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily.". J. Biol. Chem. 276 (44): 40545-54. doi:. PMID 11504738.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi:. PMID 12477932.
- Suzuki Y, Yamashita R, Shirota M, et al. (2004). "Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.". Genome Res. 14 (9): 1711-8. doi:. PMID 15342556.
- Meyer N, Petrella T, Poszepczynska-Guigne E, et al. (2005). "CD4+ CD56+ blastic tumor cells express CD101 molecules.". J. Invest. Dermatol. 124 (3): 668-9. doi:. PMID 15737213.
- Kimura K, Wakamatsu A, Suzuki Y, et al. (2006). "Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.". Genome Res. 16 (1): 55-65. doi:. PMID 16344560.
[edit] External links
 |
This membrane protein-related article is a stub. You can help Wikipedia by expanding it. |
